콘텐츠로 건너뛰기
Merck
모든 사진(1)

Key Documents

51100AST

Supelco

Astec® Cellulose DMP Chiral (5 μm) HPLC Column

L × I.D. 15 cm × 2.1 mm, HPLC Column

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
41115700
eCl@ss:
32110501
NACRES:
SB.52

product name

Astec® Cellulose DMP Chiral HPLC Column, 5 μm particle size, L × I.D. 15 cm × 2.1 mm

material

stainless steel column

Quality Level

Agency

suitable for USP L40

제품 라인

Astec®

포장

pkg of 1 ea

제조업체/상표

Astec®

파라미터

0-40 °C temperature
50 bar pressure (725 psi)

기술

HPLC: suitable

길이 × I.D.

15 cm × 2.1 mm

기질

fully porous particle
silica gel high purity, spherical
silica gel particle platform

기질 활성군

cellulose, DMPC- phase

입자 크기

5 μm

공극 크기

100 Å pore size

작동 pH

3.5-6.8

분리 기술

chiral

유사한 제품을 찾으십니까? 방문 제품 비교 안내

일반 설명

Astec® Cellulose DMP HPLC columns separate a wide range of chiral compounds under normal phase, polar organic, and SFC conditions. They exhibit high efficiency, high loading capacity, and excellent column lifetime. With performance comparable to other DMPC-derivatized cellulose CSPs, but at substantially lower price, Astec® Cellulose DMP is a must-have for every chiral column HPLC or SFC screening protocol. Astec® Cellulose DMP is complementary to the other Astec® CSPs, including CHIROBIOTIC®, CYCLOBOND and the P-CAP product lines.

Description: Spherical, porous silica coated with DMPC (dimethylphenyl carbamate)-derivatized cellulose
Particle diameter: 5 μm
Field of Use: Small molecule enantiomer separations in normal phase, polar organic, and SFC modes

추천 제품

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

법적 정보

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC
P-CAP is a trademark of Sigma-Aldrich Co. LLC

가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

적합한 버전을 찾을 수 없으신가요?

특정 버전이 필요한 경우 로트 번호나 배치 번호로 특정 인증서를 찾을 수 있습니다.

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

Katrijn De Klerck et al.
Journal of pharmaceutical and biomedical analysis, 69, 77-92 (2012-03-01)
Chirality has a significant impact on drug discovery and development processes in the pharmaceutical industry. As the number of enantiopure drugs launched onto the market is yearly increasing, the need for fast and performant enantioseparation methods with minimal costs is
Katrijn De Klerck et al.
Journal of chromatography. A, 1328, 85-97 (2014-01-21)
Since their introduction on the market the applicability of immobilized polysaccharide-based chiral stationary phases in high-performance liquid chromatography has been thoroughly investigated. These immobilized phases have the benefit to be applicable with a wide range of modifiers, potentially extending the

관련 콘텐츠

Separate a wide range of chiral compounds via normal phase, polar organic, and SFC conditions; useful in pharma, chemical, & environmental industry applications.

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.